PDCD1 and lung cancer: IHC analysis of 213 cases of human lung adenocarcinoma specimens revealed that PD-1 is preferentially expressed by CD163+ TAMs in the tumor stroma, and these stromal PD-1+ TAMs were an independent predictor of reduced survival in lung cancer patients (57).